{"name":"Janssen-Ortho Inc., Canada","slug":"janssen-ortho-inc-canada","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQblpaclpXYUx1LUZleERwQmtmeXo0VGs3NUZWUk5HMS05cWJueE1tZk42MEdnUjdxa1VlSlc3SDVGNGc5dUNCQ1VqN3I4WlNMOVUxR1cxZUR2UEVWc3piVkl6d1h3VDlWeE1NRF9mWHN1OEJ1aHR6QXRoQ0RpOGpHN2U0eHdHUWZfcHNHSnJIR2JJQ0xOWkdldFRTd040RktkZ1E?oc=5","date":"2026-02-08","type":"patent","source":"lupin.com","summary":"Lupin Launches Generic Ortho Tri-Cyclen® Tablets in the US - Lupin | Press Release - lupin.com","headline":"Lupin Launches Generic Ortho Tri-Cyclen® Tablets in the US - Lupin | Press Release","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPSE5tUmhlQUVtWFdHRUVHUXVzb2l2YjJQQjZzMjdSR21Xb0hjZ29rVU9yZzF3MnB0LWZCd3hXSkdfWUhubTJZLVgwSGc0eEZOSi1hUDI5QnFpaXMwbTV4MHpUNTF5NnpOLS1RMVI3bm9UODZ1YjRudm9TN1BROG9fYU5CRWo0NnFhQVppcEpJcm00RV85UzhlTg?oc=5","date":"2026-02-07","type":"patent","source":"lupin.com","summary":"Lupin Launches Generic Ortho Tri-Cyclen® Lo Tablets - Lupin | Press Release - lupin.com","headline":"Lupin Launches Generic Ortho Tri-Cyclen® Lo Tablets - Lupin | Press Release","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOUVBHVk5fTDVqYnhCZzZpQ2ZvRFBfZnVXUkoxdnRTTi05elFaMGh4cmlwQ1VfbzVJb1M0c3hEWlQyY3dxeFdYczFUaHVicFJFT3JlbzlYVTlPc1NXYS1EY2tOMm1aaHRBOTVHSTJpZk5INDNTTWNVeVNuV282eFl2LV96VURMMXBSZmplVV9PcGNhekV6c0JQX2V4Rjd0Yndo?oc=5","date":"2026-02-07","type":"patent","source":"lupin.com","summary":"Lupin Launches Generic Ortho-Cyclen® 28 Tablets in the US - Lupin | Press Release - lupin.com","headline":"Lupin Launches Generic Ortho-Cyclen® 28 Tablets in the US - Lupin | Press Release","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNX2FnWkRyQjQwNV8zLTlKMmNWRy1rV3pTSm93RjNFVmdvbk1kN1RESzNWUXFTUE43Q2dzaFU4YkJpY2lNeXh5aTVVRC15STdPRDVtZWpDOS1zNGtrX3ZEUlZNOGRvUFl2SVloMXdHcHBOdEtxYU9XcVpTLVFieV9acExPMU5SUVlTdVc4QkJSMXdQdFA2eGY5NDVXNXRyOGttay1NS21BNHcxUWlyZU1zUGhzaFBrc2IycUl4ZERQNFNjQjRTNHlYRGhOVHFRS3pIeEFuSm1JbVVHZTl5WkxlRE5idE1Nb2cxZ2JjQw?oc=5","date":"2024-05-02","type":"pipeline","source":"respiratory-therapy.com","summary":"Do Heartburn Medications Increase the Risk of Contracting Pneumonia? - respiratory-therapy.com","headline":"Do Heartburn Medications Increase the Risk of Contracting Pneumonia? - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOUXp4Mjl2N29zX2VzWVU3QUhsSlVoOEowbEI5LWxkTXdRY0FCdU9ZOEVxUFpWR3MyUGRkR2JqM2dRV0IxRWhiRmE5aGY1X0p1cXA2V1VidkZ4M3JPenNHTzJTcFBjWUhjQmk1bUJYUHJkdHpER1dodkZKNlRidTlJbktGcG5iQ2FYVG5fTlNMZHFOZw?oc=5","date":"2023-11-29","type":"trial","source":"CBC","summary":"Lawyer for pharma company argues against single trial in B.C. opioid damages case - CBC","headline":"Lawyer for pharma company argues against single trial in B.C. opioid damages case","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxQWnVmMGo1elIxTTNqTS00UFpRakRGenpvMEd6YjVGNTBENVNjbGlHV0JjcURVbHRPZWZ4N0h1SHMtM2NBOU1nVjN2U0lhVkZHWEVPc1JIM0JtdWg4OE9UWUxtMUlCbUNJVjh6bDFUa3Zpc3R6VzNEdTd0VjZhZUVHdW16NUdSOU5IX2JxSEc3SHpyV0RBeDJCWEtJa0l1elhxa0E5d3ZOeThSeTl5NmZoR1YtYWFPcFd6VmFfbEJlbkxGVU5ZdzdRQWJhdFJFZjlLU3dsMTBCMEhpbnRjTEotay1NRnhUVU1fUVhYYmVOMmcwaVprY3J1UF82dkZXcjhBUUtlMFpZczlIRDN6c2txbWZ0bm9yYW45b2g1VGkyalFPVG81THFQUUVsUXVrbVIxM2FlSkR6U0RSUDNfTmUtWmlKRENpUQ?oc=5","date":"2023-08-02","type":"pipeline","source":"newswire.ca","summary":"Health Canada Authorizes TECVAYLI™ (teclistamab injection), a First-in-Class Bispecific Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma - newswire.ca","headline":"Health Canada Authorizes TECVAYLI™ (teclistamab injection), a First-in-Class Bispecific Antibody for the Treatment of Pa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxNTUpRaTU5MmRSRjNnZ054Sm5HMlMxU0hPZkstLU8tYkpvME1HN2RQQW5FTzhZb1h5UHhZMXlWNDNsZHZIZURTT2RJNTROaWY1ZjdCQnA4VHVKWUVhLWJEalhKSDMzbk10SWpBYjh3NVluSnNWTm9DallHWUZWR1JhSWNPY08walhmMUNaU29QNTFZZDZ5R1dNcXRUNHJUdXp4R1R4dGdRSUhKMkVDZV8tTXZ3aEQ2MGJlREtpajV4Z0M3UnJFZ1dCVVJUazBxcDI3eUpoLUxkMTFZWHZUcXpseHNUOVdqdEtCMlkwVFRiUG8takpKN3JjWi1mZkVEeTFmS01pczBGaXpDdFROWXRKa05fVFFaWTBXZWQyNVN2b2xTYUthLWpuc214SHdYZ3BHTElTXw?oc=5","date":"2018-11-02","type":"pipeline","source":"prnewswire.com","summary":"Janssen Issues Voluntary Nationwide Recall for one lot of ORTHO-NOVUM® 1/35 and two lots of ORTHO-NOVUM® 7/7/7 Due to Incorrect Veridate® Dispenser Instructions - prnewswire.com","headline":"Janssen Issues Voluntary Nationwide Recall for one lot of ORTHO-NOVUM® 1/35 and two lots of ORTHO-NOVUM® 7/7/7 Due to In","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOVjIwYThlcFltWGlCcWFvVWl6Wk1MNm1IcHNVOXBBUlF5Q2g4UTROdGdmTVpYaWRlZ0h0T0Z2OG9QZTFUTkhZUFZMelZZTzVXTktfal8xOVdib0ZCLUhLNEIyNU9meW1GWU56V0JCTFh2MFhuRFRKNF90WXIyeXd2QjV3X0d5U2pReklEM3FKQU9PWWRKaVFOcjB4QW4xR2o0d3Z4NlozR2xlMzh6aEFuRjJYMXF2Z2diSE1ONFl2V1B2Ni1UMl9OM0JvMUJYYThw?oc=5","date":"2018-07-12","type":"patent","source":"McCarthy Tétrault LLP","summary":"Shire’s Vyvanse Patent Valid and Infringed – Federal Court Raises Key Patent Law Issues - McCarthy Tétrault LLP","headline":"Shire’s Vyvanse Patent Valid and Infringed – Federal Court Raises Key Patent Law Issues - McCarthy Tétrault LLP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPOFVpMXl3SHNHdWFjaUthek5rZjJCMDh3dVhBZFotR2hEQkdPNmNuVVdXeEFtQ1ZVOVBHeFNzM0UxNThmRjBQWVBVb1o0RE00M1pqd3otc3RLQ2wyblJVdW9USENMc0JzU2lzbkMybmhtZHRRNUk1Qm1DRkxPM1ZhTzlmNVpzYklfNE94cW50bGlXYjdhMmV1WjJBT1BKMDRhd2x4ZUJFdElIeEZnTGlhVzdjVXduX3piOUs1dEl6M3ZVWDNN?oc=5","date":"2017-12-06","type":"pipeline","source":"Top Class Actions","summary":"County Gov’t Holds Drug Companies Accountable for Opioid Epidemic - Top Class Actions","headline":"County Gov’t Holds Drug Companies Accountable for Opioid Epidemic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQb2FnN0hjSzg0STY5WXpsMGxQcGtvRHZDR2JDZktNV1FPS2FsSDZaQkFRcWxncWRaNmE1TTA5Qk1lYU5EMTV6VVdGeHB5dUoxOUR3QkRmQ0dQbXVMVTNqWS1WRTVjekN5N1gxemFrVDViRGE3V1M3a0FNQjFkT1dhcFN1Qm5IOUJlRHlKMk1NUjRFVzlHd3gwMTVLVGZnTE4wbUFzRXJzXzdTMk0?oc=5","date":"2017-11-30","type":"pipeline","source":"European Medical Journal","summary":"Developments in the Treatment and Management of Psoriasis - European Medical Journal","headline":"Developments in the Treatment and Management of Psoriasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNRmJfcFVQSmc4cE1BM3JPdVh2V1FxSmxLOVFJZkJEb0xna2pGay1iLXdUZkVjbWNleTBQTnFmcmZUZXk2cE0zbE0yclFHb3o5NE13NENINjRwaDk5NDU3ZGpqeHdPMzEtbkJSV3RhRUR3WTduQ09jZmJySEJ6cnhrS2dIWGlWbUpnYUtkWE5NWE1jaFMycnV3cm9qY1RfLVd0OWR0TEdCUURUY0lQMzY5bHVick1iSTMyRDJZWGlPMTVLUXVQN1RTc25tYklXaldkemVuX0ZfVkhXM2podktLQXlUd2FtZU9kS3M0?oc=5","date":"2017-06-19","type":"pipeline","source":"The Globe and Mail","summary":"The pressure of Big Pharma: Financial conflicts of interest common on medical guideline panels - The Globe and Mail","headline":"The pressure of Big Pharma: Financial conflicts of interest common on medical guideline panels","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFA5ek90RzJxekc1TTlIOF9SbVNCMjJ6dGpNcVNSWmlRNzdvcERoTnZLMkFyaWdwT2NoNU8zZGRvX2FqeldhWWVwQnR2R2dqbF9ETXFRQ2ZWYmFWbml2ZXNxYWx6dmhHZjh5N1RDQVVhSHFMb0ZOV3gyYw?oc=5","date":"2008-09-16","type":"regulatory","source":"fiercebiotech.com","summary":"Bayer's Xarelto Approved in Canada - fiercebiotech.com","headline":"Bayer's Xarelto Approved in Canada","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}